Updates on acute severe UC by Jordan Axelrad, MD, MPH at NYU Langone Health #biggutIBD ! CDI+ is a poor prognostic factor, inpatient IFX 5 mg/kg 🟰 10mg/kg, and JAKi are now an effective option (but can still use cyclo☝️)

Incredible line while giving a presentation during the earthquake: “This is how impactful IUS (Intestinal Ultrasound) is in IBD care … It shakes the earth”. #BigGutIBD2024

⁦Millie Long⁩ talking precision medicine at #biggutIBD ⁦NYU Langone Health⁩.
Next stop: breaking the therapeutic ceiling 🔨

Keynote lecture by Millie Long on the current status of precision 💊 in IBD NYU Langone Health #biggutibd

Some 🔑:
1️⃣ Profile UK: 🚫 utility of PredictSURE, but DID show benefit of early combo
2️⃣ Can use HLA-DQ A1*05, TPMT & NUDT15 to guide TNFa/IMM
3️⃣ TL1A’s (+ companion dx) on the way!

Outstanding talk Ariela Holmer on transitioning from peds —> adult care in #IBD
—Education is 🔑
David Hudesman Shannon Chang, MD Simon Hong Jordan Axelrad, MD, MPH Sophie Balzora, MD, FACG Brad Morganstern, MD NYU Grossman School of Medicine

Amazing talk Sophie Balzora, MD, FACG on Social Determinants of Health in #IBD
🚨impact —> higher food insecurity, lower social support, increased hospitalization, lower used of advanced therapies- inclusion in RCTs
impt to move from equality —> equity ABGH David Hudesman

Giving an #IUS talking during an earthquake…that’s a first 😅

Dr. Lisa Malter presents the newer paradigm in the treatment pyramid for mod/severe #Crohns . Importantly, steroids are no longer included in the pyramid given its ADEs and use only in the short term. Undertreatment is also considered an ADE of sorts. Impt shift in mindset! #IBD

NYU Langone Health #BigGut2024 happening now! Fantastic talks by #LisaMalter & Gil Y. Melmed, MD, MS on first and second line treatments for #IBD Millie Long David Hudesman Shannon Chang, MD Jordan Axelrad, MD, MPH Sophie Balzora, MD, FACG Ariela Holmer Simon Hong

Kicking off NYU Langone Health Big Gut IBD 2024! Gil Y. Melmed, MD, MS reviews 1st-line 💉💊 for UC. Some highlights:
▶️ RCTs finally assessing proctitis and urgency
▶️ small molecules continue to show rapid onset of action
▶️ NO matter what you choose from
the “buffet” - monitor and T2T!

Surgery as first-line option in #IBD Shannon Chang, MD ✨
—> limited remission rates with current advanced therapies
—> 🚨delaying surgery when ultimately required can lead to inc AEs
Gil Y. Melmed, MD, MS Millie Long David Hudesman Sophie Balzora, MD, FACG Jordan Axelrad, MD, MPH Ariela Holmer Simon Hong

Join us this Friday NYU Langone Health for the best yet Big Gut #IBD !!

Two more weeks to go! David Hudesman Adam Faye MD MS Ariela Holmer Simon Hong Jordan Axelrad, MD, MPH Brad Morganstern, MD

This caught my attention since it very much reflects my experience dealing with coverage of biologics for patients with #IBD Insurance Companies' Poor Adherence to Guidelines for... : Official journal of the American College of Gastroenterology | ACG journals.lww.com/ajg/abstract/9…

Join us for our annual #IBD course on April 5th NYU Langone Health with guests of honor Gil Y. Melmed, MD, MS Millie Long!

Excited to be part of the team! Stay tuned for updates throughout the year on the latest research from IBDJournal & CC360 Crohn's & Colitis Foundation

Much needed 🙏 GI Grand Rounds on updates in C.diff testing and therapeutics by Jordan Axelrad, MD, MPH NYU Langone Health NYU Department of Medicine

Some 🔑:
1. PCR = presence of 🦠, need EIA to confirm toxin (true infxn)
2. Dificid > vanc
3. Now ✌️ FDA-approved 💩 avail! Rebyota and Vowst

🎉Our review on the mgmt of Older Adults with IBD out this month and featured in Gastro Hep
Outstanding work by our amazing fellow #EllenAxenfeld NYU Grossman School of Medicine Aasma Shaukat MD MPH John Dodson @JChodoshMD Clin-STAR Coordinating Center Dorry Segev #MaraMcAdamsDemarco #SyKatz

gastroenterologyandhepatology.net/archives/octob…

4⃣5⃣ for #ColorectalCancer Screening

📣Average risk individuals should begin screening for #ColorectalCancer at age 45!

The College and the #GIcommunity stand together with patient advocates and public health experts who know the evidence.

Patient info: gi.org/coloncancer

Huge congrats to Jordan Axelrad, MD, MPH celebrating the launch of the Axelrad Lab. So proud of all his accomplishments, and can’t wait to see what the future holds. NYU Langone Health